Protein kinase A-dependent activation of PDE4 (cAMP-specific cyclic nucleotide phosphodiesterase) in cultured bovine vascular smooth muscle cells.

[1]  E. Degerman,et al.  Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. , 1995, Archives of biochemistry and biophysics.

[2]  J. Grande,et al.  Inhibitors of Cyclic Nucleotide Phosphodiesterase Isozymes Type-lil and Type-iv Suppress Mitogenesis of Rat Mesangial Cells Key Words: Camp-dependent Protein Kinase * Ciostamide - Rolipram * Epidermal Growth Factor * Mitogen-activated , 2022 .

[3]  A. Hatzelmann,et al.  PDE isoenzymes as targets for anti-asthma drugs. , 1995, The European respiratory journal.

[4]  A. Stewart,et al.  Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. , 1995, Biochemical pharmacology.

[5]  M. Conti,et al.  Recent progress in understanding the hormonal regulation of phosphodiesterases. , 1995, Endocrine reviews.

[6]  R. A. Murphy,et al.  Cyclic nucleotide dependent relaxation in vascular smooth muscle. , 1994, Canadian journal of physiology and pharmacology.

[7]  H. Lübbert,et al.  Expression and regulation of human and rat phosphodiesterase type IV isogenes , 1994, FEBS letters.

[8]  J. Polson,et al.  Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells. , 1994, Biochemical pharmacology.

[9]  M. Lagarde,et al.  Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. , 1993, Molecular pharmacology.

[10]  K. Jarnagin,et al.  The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family. , 1993, Gene.

[11]  G. Hassall,et al.  Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors. , 1992, Biochemical pharmacology.

[12]  M. Giembycz.  Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? , 1992, Biochemical pharmacology.

[13]  I. Hall,et al.  Effects of isozyme selective phosphodiesterase inhibitors on bovine tracheal smooth muscle tone. , 1992, Biochemical pharmacology.

[14]  C. Lugnier,et al.  Endothelium‐dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors , 1991, British journal of pharmacology.

[15]  D. Blanchard,et al.  Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes. , 1991, Biochemical pharmacology.

[16]  B. Undem,et al.  Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. , 1991, Thorax.

[17]  R. Haslam,et al.  Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aortic smooth muscle. , 1990, European journal of pharmacology.

[18]  T. Andersson,et al.  Effects of isozyme-selective phosphodiesterase inhibitors on rat aorta and human platelets: smooth muscle tone, platelet aggregation and cAMP levels. , 1990, Acta physiologica Scandinavica.

[19]  J. Beavo,et al.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. , 1990, Trends in pharmacological sciences.

[20]  D. Crossman,et al.  Action of calcitonin gene‐related peptide upon bovine vascular endothelial and smooth muscle cells grown in isolation and co‐culture , 1990, British journal of pharmacology.

[21]  M. Conti,et al.  The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Davis,et al.  Cloning and characterization of mammalian homologs of the Drosophila dunce+ gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Londos,et al.  A tandem chromatographic column method for assaying cAMP-dependent protein kinase and protein kinase C with synthetic peptide substrates. , 1988, Analytical biochemistry.

[24]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[25]  R. Challiss,et al.  Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. , 1991, TIPS - Trends in Pharmacological Sciences.

[26]  J. Beavo,et al.  Cyclic nucleotide phosphodiesterases : structure, regulation and drug action , 1990 .